← Back to Clinical Trials
Recruiting NCT07273136

NCT07273136 Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07273136
Status Recruiting
Phase
Sponsor Assiut University
Condition Subcostal
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-12-10
Primary Completion 2026-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Subcostal and lateral transversus abdominis plane blockThoracic epidural anesthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-12-10 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the safety and efficacy of combined subcostal and lateral transversus abdominis plane (TAP) for postoperative analgesia versus thoracic epidural anesthesia (TEA) in patients undergoing major abdominal cancer surgery.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-III. * Scheduled for major abdominal surgeries including: (e.g., gastrectomy, colectomy, hepatectomy, cystectomy, total abdominal hysterectomy, Nephrectomy, pancreatectomy). Exclusion Criteria: * Intraoperative hemodynamic instability. * History or evidence of coagulopathy. * Infection or abdominal wall masses at injection site. * Morbid obesity. * Other Medical conditions including mental illness or substance abuse. * Known allergy to local anesthetics. * Chronic opioid use or chronic pain conditions. * Pregnancy.

Contact & Investigator

Central Contact

Bahaa G Saad, MD

✉ bahaagamal@aun.edu.eg

📞 00201555590977

Frequently Asked Questions

Who can join the NCT07273136 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Subcostal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07273136 currently recruiting?

Yes, NCT07273136 is actively recruiting participants. Contact the research team at bahaagamal@aun.edu.eg for enrollment information.

Where is the NCT07273136 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT07273136 clinical trial?

NCT07273136 is sponsored by Assiut University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology